CVE-2024-41668 Details
UNDERGOING ENRICHMENT
The CVE is currently being enriched by the Volerion team. The enrichment process results in the association of reference link tags, CVSS, and CPE applicability statement data.
Description
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.
Metrics
CVSS 4.0 Severity and Vector Strings:
VolerionCVSS-B:…Vector:This vulnerability is currently being analyzed.No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
VolerionCVSS-B:…Vector:This vulnerability is currently being analyzed.No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Jul 25, 2024References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-918 | Server-Side Request Forgery (SSRF) | [email protected] |
Affected Products
This vulnerability is currently being analyzed
Change History
4 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Nov 21, 2024 | CVE Modified | CVE |
| Jul 23, 2024 | New CVE Received | [email protected] |